Description: ToolGen Incorporated, a biotechnology company, focuses on the development of genome editing technology in South Korea. The company develops clustered regularly interspaced short palindromic repeats (CRISPR)-Cas9 gene scissors for gene editing in eukaryotic cells. It is involved in patent monetization, treatment, and seed businesses. ToolGen Incorporated was founded in 1999 and is based in Seoul, South Korea.
Home Page: www.toolgen.com
172 Magokjungang-ro
Seoul,
South Korea
Phone:
82 2 3660 1300
Officers
Name | Title |
---|---|
Joon Lee Jung | Research Head of Platform Development Team |
Mr. Young Ho Kim | CEO & Chairman of the Board |
Byong Hwa Lee | President & CEO |
Mr. Jin-Soo Kim | Co-Founder & Member of The Board of Directors |
Mr. Sang Koo Yoon | Chief Financial Officer and Member of The Board of Directors |
Yoori Kim | Executive VP & Chief Legal Officer |
Soon Il Kwon | Head of Seed Research 1 Division |
Jae young Lee | Head of Therapeutic Development |
Hyun Young Koo | Head of Business Development Division |
So Han Kim | Head of Clinical & Regulatory Strategy |
Exchange: KQ
Country: KR : Korea (Republic of)
Currency: Korean Won (₩)
GIC Sector: | Health Care |
---|---|
GIC Group: | Pharmaceuticals, Biotechnology & Life Sciences |
GIC Industry: | Biotechnology |
GIC Sub-Industry: | Biotechnology |
Forward PE: | 0 |
---|---|
Trailing PE: | 0 |
Price-to-Book MRQ: | 22.0774 |
Price-to-Sales TTM: | 305.0951 |
IPO Date: | |
Fiscal Year End: | December |
Full Time Employees: | 81 |